Report on Psychedelics

Report on Psychedelics

By Report on PsychedelicsBusinessMedicineHealth & FitnessMental HealthInvesting
Download on the App Store

Report on Psychedelics episodes

  • RoP Briefing: March 2
    In This Week’s Briefing:
    MindMed Goes Public, Raises $24M USD
    Mushrooms of all types are having their moment
    Another cannabis company pivots to psychedelics
    Don’t forget about the risks
    6 min
  • RoP Briefing: February 24
    In this week’s Briefing:
    Psilocybin Challenge Expected in Canadian Federal Court
    Washington D.C. Approves Decriminalization Ballot Language
    As Denver’s Psilocybin Review Panel Meets, Activists Eye Neighboring Boulder
    Silicon Valley Hacks Mental Health
    6 min
  • RoP Briefing: February 18
    In this week’s Briefing:
    MindMed Gets Set to Go Public On Stock Exchange
    US States are lining up to consider legalizing psychedelics
    Australian State recommends decriminalizing MDMA and Cannabis
    Researchers contemplate Love and Drugs
    6 min
  • RoP Briefing: February 10
    In this week’s Briefing:
    MAPS gets Expanded Access Approval From FDA
    COMPASS granted a US Patent
    Field Trip Health builds war chest
    Santa Cruz Decriminalizes
    U.K. says NO to Eskatamine
    5 min

About Report on Psychedelics

From the publisher's feed

Report on Psychedelics is the leading source of independent data and intelligence for the emerging psychedelics industry.